Senior insider sale
Chief Financial Officer at KYMERA THERAPEUTICS, INC. — senior position signals high conviction
$8.43M
77.11K shares
What this filing means
JACOBS BRUCE N. plans to sell 77.11K shares of KYMERA THERAPEUTICS, INC. valued at approximately $8.43M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/30/2026ACC: 0001950047-26-006647
Officer· Chief Financial Officer
Since Aug 2020
77.11K
Shares to sell
$8.43M
Approx. market value
77.11K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
6/30/2026
61.38KRestricted Stock Units
N/A
3/1/2025
15.73KTotal acquired77.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/30/2026 | Exercise of Stock Options Cash | 61.38K | — |
3/1/2025 | Restricted Stock Units N/A | 15.73K | — |
| Total | 77.11K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
77.11K
Market value
$8.43M
6/30/2026
Total
Units
77.11K
Value
$8.43M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/30/2026 | 77.11K | $8.43M | NASDAQ | Planned |
| Total | 77.11K | $8.43M | ||